Citation Impact
Citing Papers
Acute Phase Proteins with Special Reference to C-Reactive Protein and Related Proteins (Pentaxins) and Serum Amyloid A Protein
1983 Standout
Genetically Driven Hyperglycemia Increases Risk of Coronary Artery Disease Separately From Type 2 Diabetes
2017
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
2012 Standout
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Pharmaceutical Particle Engineering via Spray Drying
2007 Standout
Relating mean blood glucose and glucose variability to the risk of multiple episodes of hypoglycaemia in type 1 diabetes
2007
The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives
2011 Standout
The emerging challenge in diabetes: The “metabolic memory”
2012
Complementing Insulin Therapy to Achieve Glycemic Control
2013
Wearable biosensors for healthcare monitoring
2019 Standout
Assessment of Cardiovascular Autonomic Function: Age‐related Normal Ranges and Reproducibility of Spectral Analysis, Vector Analysis, and Standard Tests of Heart Rate Variation and Blood Pressure Responses
1992
Chronic inflammation in the etiology of disease across the life span
2019 Standout
Beneficial effects of a long-term oral l -arginine treatment added to a hypocaloric diet and exercise training program in obese, insulin-resistant type 2 diabetic patients
2006
Attainment of glycaemic goals in type 2 diabetes with once‐, twice‐, or thrice‐daily dosing with biphasic insulin aspart 70/30 (The 1‐2‐3 study)
2005
Prandial Premixed Insulin Analogue Regimens Versus Basal Insulin Analogue Regimens in the Management of Type 2 Diabetes: An Evidence-Based Comparison
2007
Dietary Advanced Glycation End Products and Their Potential Role in Cardiometabolic Disease in Children
2016 Standout
Targeting oxidative stress in disease: promise and limitations of antioxidant therapy
2021 Standout
An overview of the rationale for pharmacological strategies in type 2 diabetes: from the evidence to new perspectives
2005
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
2015 Standout
The biology of incretin hormones
2006 Standout
The Treat-to-Target Trial and Related Studies
2006
Amino acids: metabolism, functions, and nutrition
2009 Standout
Neurogenic heterotopic ossification in spinal cord injury
2002
Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease
2014 Standout
Low-Intensity Exercise Reduces the Prevalence of Hyperglycemia in Type 2 Diabetes
2010
Adhesive Capsulitis of the Shoulder: Current Concepts and Treatment
1988
Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians
2018 Standout
Engineering digital biomarkers of interstitial glucose from noninvasive smartwatches
2021
A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study
2006
Options for the intensification of insulin therapy when basal insulin is not enough in type 2 diabetes mellitus
2008
Biology of Incretins: GLP-1 and GIP
2007 Standout
Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study
2019 Standout
High–glycemic index carbohydrate increases nuclear factor-κB activation in mononuclear cells of young, lean healthy subjects
2008
GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus
2012
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
2015 Standout
Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial
2008
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
2006 Standout
Type 2 diabetes
2017 Standout
Postprandial Glucose Regulation and Diabetic Complications
2004
The safety and efficacy of liraglutide with or without oral antidiabetic drug therapy in type 2 diabetes: an overview of the LEAD 1–5 studies
2009
A review of human and analogue insulin trials
2006
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2012 Standout
Traumatic spinal cord injury
2017 Standout
The A1C and ABCD of glycaemia management in type 2 diabetes: a physician's personalized approach
2010
Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: A multinational, randomized, open-label, two-period, crossover noninferiority trial
2007
Microneedles for drug and vaccine delivery
2012 Standout
Type 2 diabetes mellitus
2015 Standout
Ethnopharmacological uses, phytochemistry, biological activities, and therapeutic applications of Clinacanthus nutans (Burm. f.) Lindau: A comprehensive review
2017 Standout
Efficacy of berberine in patients with type 2 diabetes mellitus
2008 Standout
End-to-end design of wearable sensors
2022 Standout
Efficacy and tolerability of vildagliptin in drug‐naïve patients with type 2 diabetes and mild hyperglycaemia*
2008
Reporting quality of randomized trials in the diet and exercise literature for weight loss
2005
Sustained IL-1α, IL-4, and IL-6 elevations following correction of hyperglycemia in children with type 1 diabetes mellitus
2008
Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial
2021
Protein therapeutics: a summary and pharmacological classification
2007 Standout
A Stepwise Approach to Insulin Therapy in Patients with Type 2 Diabetes Mellitus and Basal Insulin Treatment Failure
2011
Arginine metabolism and nutrition in growth, health and disease
2008 Standout
Activation of Oxidative Stress by Acute Glucose Fluctuations Compared With Sustained Chronic Hyperglycemia in Patients With Type 2 Diabetes
2006 Standout
Introducing a simplified approach to insulin therapy in type 2 diabetes: a comparison of two single‐dose regimens of insulin glulisine plus insulin glargine and oral antidiabetic drugs
2008
The Incretin Mimetic Exenatide as a Monotherapy in Patients with Type 2 Diabetes
2007
Review of Phase 2 Studies Utilizing the AIR ® Particle Technology in the Delivery of Human Insulin Inhalation Powder Versus Subcutaneous Regular or Lispro Insulin in Subjects with Type 1 or Type 2 Diabetes
2007
Microneedle-Based Intradermal Versus Subcutaneous Administration of Regular Human Insulin or Insulin Lispro: Pharmacokinetics and Postprandial Glycemic Excursions in Patients with Type 1 Diabetes
2011
Citrus polymethoxyflavones attenuate metabolic syndrome by regulating gut microbiome and amino acid metabolism
2020 Standout
From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus
2009 Standout
Improved Cardio-Respiratory Fitness Correlates with Changes in the Number and Size of Small Dense LDL: Randomized Controlled Trial with Exercise Training and Dietary Instruction
2009
Wearable Contact Lens Biosensors for Continuous Glucose Monitoring Using Smartphones
2018
EFFECTIVE RECRUITMENT AND RETENTION OF MINORITY RESEARCH PARTICIPANTS
2005 Standout
Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy
2008 Standout
Randomized, double-blind, placebo-controlled, clinical study on the effect of Diabetinol® on glycemic control of subjects with impaired fasting glucose
2015
Efficacy and Safety of the Once-Daily GLP-1 Receptor Agonist Lixisenatide in Monotherapy
2012
Tirzepatide Once Weekly for the Treatment of Obesity
2022 Standout
Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
2014 Standout
Type 2 diabetes mellitus, oxidative stress and inflammation: examining the links.
2019
Increased Granulocyte Adherence in Psoriasis and Psoriatic Arthritis
1980
Consensus Report: The Current Role of Self-Monitoring of Blood Glucose in Non-Insulin-Treated Type 2 Diabetes
2011
Benfotiamine Prevents Macro- and Microvascular Endothelial Dysfunction and Oxidative Stress Following a Meal Rich in Advanced Glycation End Products in Individuals With Type 2 Diabetes
2006
Myocardial Fatty Acid Metabolism in Health and Disease
2010 Standout
Importance of Assessing Cardiorespiratory Fitness in Clinical Practice: A Case for Fitness as a Clinical Vital Sign: A Scientific Statement From the American Heart Association
2016 Standout
A 26-Week, Randomized, Parallel, Treat-to-Target Trial Comparing Insulin Detemir With NPH Insulin as Add-On Therapy to Oral Glucose-Lowering Drugs in Insulin-Naive People With Type 2 Diabetes
2006
A Real-World Approach to Insulin Therapy in Primary Care Practice
2005
Polymorphonuclear Leukocyte Function in Psoriasis: Chemotaxis, Chemokinesis, Beta-Adrenergic Receptors, and Proteolytic Enzymes of Polymorphonuclear Leukocytes in the Peripheral Blood from Psoriatic Patients
1983 StandoutNobel
Postprandial Hyperglycemia and Diabetes Complications
2005
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018 Standout
Deep learning with long short-term memory networks for financial market predictions
2017 Standout
Pharmacological Treatment of the Pathogenetic Defects in Type 2 Diabetes
2010
Exenatide versus Insulin Glargine in Patients with Suboptimally Controlled Type 2 Diabetes
2005
Pathophysiology of Type 2 Diabetes Mellitus
2020 Standout
International Diabetes Center Treatment of Type 2 Diabetes Glucose Algorithm
2011
Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments
2010 Standout
‘Gastric’ hypoglycaemia – an important concept in diabetes management
2006
Efficacy and Safety of Inhaled Insulin (Exubera) Compared With Subcutaneous Insulin Therapy in Patients With Type 2 Diabetes
2004
Insulin Glulisine Provides Improved Glycemic Control in Patients With Type 2 Diabetes
2004
Shoulder disorders in general practice: incidence, patient characteristics, and management.
1995 Standout
Circulating immune complexes, serum immunoglobulins, and acute phase proteins in psoriasis and psoriatic arthritis.
1981
Physical Activity/Exercise and Diabetes: A Position Statement of the American Diabetes Association
2016 Standout
Differences in Cardiovascular Risk Profile of Diabetic Subjects Discordantly Classified by Diagnostic Criteria Based on Glycated Hemoglobin and Oral Glucose Tolerance Test
2010
Diabetic Autonomic Neuropathy
2003 Standout
Initiating Insulin Therapy in Type 2 Diabetes
2005
Review of basal‐plus insulin regimen options for simpler insulin intensification in people with Type 2 diabetes mellitus
2017
Comparison of Effect of Pioglitazone With Metformin or Sulfonylurea (Monotherapy and Combination Therapy) on Postload Glycemia and Composite Insulin Sensitivity Index During an Oral Glucose Tolerance Test in Patients With Type 2 Diabetes
2005
Continuous Glucose Monitoring Systems: A Review
2013
Works of H Lapinski being referenced
Energy metabolism and substrates oxidative patterns in type 2 diabetic patients treated with sulphonylurea alone or in combination with metformin
2000
Self-monitoring of blood glucose in diabetic patients: from the least common denominator to the greatest common multiple
2004
Global assessment for quality and safety of control in type 2 diabetic patients
2004
Continuous glucose monitoring in patients with type 2 diabetes: Why? When? Whom?
2007
Lack of association between HLA‐B27 and frozen shoulder
1981
Short and Long Term Effects of Radioiodine and Antithyroid Drugs on T4 Binding Proteins, Free T4 and T3, during Graves' Disease Therapy
1977
HLA and neurogenic paraosteoarthropathies
1983
Contributions of Fasting and Postprandial Plasma Glucose Increments to the Overall Diurnal Hyperglycemia of Type 2 Diabetic Patients
2003
Immunological aspects of psoriasis.
1976
Morning Hyperglycemic Excursions
2002